<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02873533</url>
  </required_header>
  <id_info>
    <org_study_id>2011/11 MEGERIA</org_study_id>
    <nct_id>NCT02873533</nct_id>
  </id_info>
  <brief_title>Modification of the Quality of Life Based on Objective Geriatric Tests</brief_title>
  <acronym>MEGERIA</acronym>
  <official_title>Pilot Project - Prospective Longitudinal Cohort of Patients Over 70 Years With Malignant Solid Tumors: Modification of Quality of Life Based on Objective Geriatric Tests</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Antoine Lacassagne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Antoine Lacassagne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The analysis of this study will achieve an improvement in the management of patients over 70&#xD;
      years with adaptation of chemotherapy regimens after analysis of the subject and its&#xD;
      psychosocial environment.&#xD;
&#xD;
      The analysis of socio-economic impacts will implement actions to optimize the care of the&#xD;
      elderly while emphasizing the value of management / cost of care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Quality of life is defined as &quot;an individual's perception of his place in life, in the&#xD;
      context of culture and value system in which he lives, in relation to its goals,&#xD;
      expectations, standards and concerns &quot;(WHO 1993).&#xD;
&#xD;
      This concept refers to multiple dimensions, both objective and subjective:&#xD;
&#xD;
        -  The physical condition of the person, his functional abilities;&#xD;
&#xD;
        -  His somatic sensations;&#xD;
&#xD;
        -  His psychological health;&#xD;
&#xD;
        -  His social status, relational environment.&#xD;
&#xD;
      This concept focuses on perception's basics. Quality of life is a criteria supposed to be&#xD;
      objective even though it is subject to subjective interpretation at the highest point.&#xD;
      Indeed, if the quality of life varies depending on the discretion of each person, it also&#xD;
      changes over time: it refers to a situation at a given moment and not to a stable state.&#xD;
&#xD;
      Therefore in this study, it seemed appropriate to show the concept of &quot;quality of life&#xD;
      objective&quot; which is linked to objective data measures recognized criteria for evaluating the&#xD;
      elderly. These criteria are repeatable, validated and not dependent operator.&#xD;
&#xD;
      This process completely matches with the actions promoted by the 2009-2013 Cancer Plan&#xD;
      (measures 23 and 26) on the basis of an improvement of:&#xD;
&#xD;
        -  The quality of consideration of the psychosocial dimension (customization accompaniment,&#xD;
           living environment, social, involvement, ..)&#xD;
&#xD;
        -  The quality of the integration of physical and psychological dangers inherent to this&#xD;
           weakness situation induced by cancer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">April 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measuring quality of life according to geriatric questionnaires</measure>
    <time_frame>36 months</time_frame>
    <description>Activities of Daily Living Questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Geriatric Screening Test fragilities and comorbidities</measure>
    <time_frame>36 months</time_frame>
    <description>Mini Mental State Examination</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Cancer</condition>
  <condition>Elderly Patients</condition>
  <arm_group>
    <arm_group_label>A-Elderly patients with cancer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>geriatric care and longitudinal follow up</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>geriatric care and longitudinal follow up</intervention_name>
    <description>geriatric care and longitudinal follow up</description>
    <arm_group_label>A-Elderly patients with cancer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient over 70 years,&#xD;
&#xD;
          -  Patient with a solid malignant tumor,&#xD;
&#xD;
          -  Patients for whom a first line chemotherapy is theoretically indicated&#xD;
&#xD;
          -  Patient chemotherapy naive,&#xD;
&#xD;
          -  Performance Index (PS) &lt;4&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient not understanding or do not speak French,&#xD;
&#xD;
          -  Patients with any severe psychopathological disorder preventing the completion of the&#xD;
             questionnaire or invalidating a priori measures of the questionnaire&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>VÃ©ronique MARI, md</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Antoine Lacassagne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Antoine LACASSAGNE</name>
      <address>
        <city>Nice</city>
        <zip>06189</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <study_first_submitted>August 11, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2016</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

